Concepedia

Hideaki Suna

HS

Statistics

Publications

9

Citations

502

H-Index

9

Active since

2003

Affiliations

Ono Pharmaceutical (Japan)(Current)

The University of Osaka

Lampung University

National Cancer Center Hospital East

Aichi Cancer Center

Hideaki Suna is an author at Ono Pharmaceutical (Japan) specializing in pharmacology, medicine, and life sciences.

Publications per year

2003–2022

9

Publications

9

A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors

Toshihiko Doi, Kei Muro, Hiroshi Ishii et al. · Clinical Cancer Research · 2019 · 152 citations

Medicine, Oncology, Pharmacology +17

Structure–activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids

Shunji Aoki, Yasuo Watanabe, D. Tanabe et al. · Bioorganic & Medicinal Chemistry · 2007 · 96 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner

Shunji Aoki, Dexin Kong, Hideaki Suna et al. · Biochemical and Biophysical Research Communications · 2006 · 63 citations

Life Sciences, Molecular Biology, Pharmacology +14

Elevation of serum acid phosphatase in Gaucher's disease.

Tuchman Lr, Hideaki Suna, Carr Jj · PubMed · 2003 · 52 citations

Life Sciences, Biochemistry, Pathology +5

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Hirotaka Hasegawa, Kohei Shitara, Shuji Takiguchi et al. · Gastric Cancer · 2022 · 36 citations · Full text

Medicine, Oncology, Surgery +16

1–5 of 9